article thumbnail

CMS: Health spending grew by 7.5% in 2023 amid increase in insurance coverage, care utilization

Fierce Healthcare

Healthcare spending reached nearly $5 trillion in 2023, growing by 7.5% Healthcare spending reached nearly $5 trillion in 2023, growing by 7.5% from the prior year, according to new data from the federal government. from the prior year, according to new data from the federal government.

article thumbnail

CMS projects national health spending grew 7.5% in 2023 to $4.8T

Fierce Healthcare

National health spending is estimated to have outpaced the rest of the country’s economy in 2023, growing by 7.5% with projected expenditures of $4.8

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Net prices for medicines fell considerably in 2023’s last quarter, mostly thanks to Humira biosimilars

STAT

Over the past year, nine biosimilar versions of the medicine were launched by other companies seeking favorable placement on formularies, the lists of drugs for which health insurance coverage is available.

article thumbnail

CDC advisory panel opts for a go-slow approach on expanding usage of RSV vaccines

STAT

Makers of RSV vaccines for older adults saw their plans to try to expand usage hit a significant hurdle on Wednesday, when an expert committee that advises the Centers for Disease Control and Prevention on vaccines recommended changes that will likely see fewer older adults qualify for insurance coverage for these products.

Vaccines 127
article thumbnail

Health insurance statistics 2023

The Checkup by Singlecare

million people (8.3%) not having health insurance at any point during 2021. Census Bureau , 2022) The most popular to least popular type of health insurance coverage in 2021 were employer-based insurance (54.3%), Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA or CHAMPVA insurance (1%). (

article thumbnail

The popular inhaler Flovent has been discontinued

The Checkup by Singlecare

In 2023, Flovent manufacturer GlaxoSmithKline (GSK) announced their decision to discontinue Flovent-branded products starting January 1, 2024. The authorized generics were introduced in May 2022 and October 2023 but will be used exclusively starting January 1, 2024. Not all alternatives will have the same insurance coverage.

Insurance 105
article thumbnail

Lilly defers Alzheimer’s drug filing after CMS’ ‘disappointing’ decision

pharmaphorum

Lilly is a little vague on when it will now file donanemab with the FDA – suggesting on its fourth quarter 2021 results call that it may do so later this year – but reiterated that it has little hope of the drug being used ahead of the readout of TRAILBLAZER-ALZ 2 in mid-2023.